100 implants on the 2cd of april.
108 implants on the 26th of april.
119 implants on the 4th of june.
17 centres online....40 planned.
It's probably safe to say when all centres online,implants will be 25 to 30 implants per month.
There's no shortage of candidates remember.
360 implants possible in next 12 months and by that time the data will be being reviewed by the relevant authorities due to the innovative protocol in place.
Therefore commercialism in the US 15 months or earlier.
Revenue with all of the above being true i think could be NFY in the order of $20 to $25 million.
Still no profit but i'm sure the year after will generate a profit.
The Ventrassist will be the preffered LVAD for at least the next 3 or 4 years,the rest of the opposition will have to catch up.
And thats on the proviso they stand up to the trials ahead...heartmate 3 already kaput.
- Forums
- ASX - By Stock
- VCR
- full steam ahead
VCR
ventracor limited
full steam ahead
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.